Pre-treatment of IOZCAS-Spex-II cells with CPT and HCPT decreased Topo1 specific activity in a dose-dependent manner. by Lan Zhang (90951)

Mean value of ENSS and subscales. by Phu Dinh Vu (19429477)

“…Overall, participants reported a medium stress level with an Extended Nursing Stress Scale (ENSS) mean score of 1.79 points, and 32.1% had occupational stress. …”

Decreased IFNγ production by BcA9 NK cells is independent of impaired MAP kinase pathway signaling or RNA instability. by Nassima Fodil (669326)

Flagella numbers and flagellar class II and class III gene expression are decreased in a Δ<i>rfaG</i> mutant. by Julia Andrea Deditius (782678)

Likelihood of a decrease in runoff (a), an increase in runoff (b) and a severe change in ecosystems (c) for selected Δ<em>T</em>_g levels by Dieter Gerten (557088)

“…</strong> Likelihood of a decrease in runoff (a), an increase in runoff (b) and a severe change in ecosystems (c) for selected Δ<em>T</em>_g levels. …”

A Yoga Strengthening Program Designed to Minimize the Knee Adduction Moment for Women with Knee Osteoarthritis: A Proof-Of-Principle Cohort Study by Elora C. Brenneman (795723)

“…A secondary objective was to determine whether the program could improve mobility and fitness, and decrease peak KAM during gait. …”

rhIL-4 and rhIL-13 decrease LEC proliferation and downregulate expression of Prox-1. by Ira L. Savetsky (749034)

TR4 and TR9 decrease hepatoma cell viability at a lower TC50 than Sorafenib, SAHA or 5-Fluorouracil. by Nicole Lange (335740)

Binary and ordinal logistic regression analysis of predictors for the occurrence of ISR > 50%. by Jae-Chan Ryu (2850581)

Reduced follicles, decreased ovulation and decreased fertilization of female Meox-2-cre/Separase S1121A mutant mice. by Juan Xu (225010)

Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy by Yong-Chul Kim (1637572)

“…</p><p>Results</p><p>The mean value of pcUACR at 12-week and 16-week visits (primary outcome) was decreased more in the Tac group compared to the control group (–52.0±26.4 vs –17.3±29.3%, p = 0.001). …”

The <i>ΔcchA</i>, <i>ΔmidA</i>, and <i>ΔyvcA</i> strains have decreased accumulation of calcium in the cytoplasm. by Patrícia Alves de Castro (532465)

Decrease in comet tail moment (TM) with increasing concentration of () melphalan and () SJG-136 in AA8 cells by Peter H. Clingen (9612)

“…For each drug concentration, the TM of 50 cells was measured and the mean values calculated. …”

IL-2 accumulation decreases in response to viable <i>P. gingivalis</i> and its derived supernatant. by Hazem Khalaf (308041)

Effects of the adipokines resistin, visfatin, leptin, and adiponectin on androstenedione production <i>in</i><i>vitro</i> in the presence of LH: compared to control cells, adiponectin treatment (3μg/mL) decreased levels of androstenedione in medium (****p= <0.0001) when bovine theca cells were treated with LH and insulin (both at 100 ng/mL). by Fabio V. Comim (486376)

COMP-Ang-1 treatment (100 ng/ml) effect of ob/ob and ob/+ mice on lipid profile after 21 days. by Joanna Kosacka (330426)

Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. by Yang Zhang (30734)

LiCl and MTR decrease polyQ toxicity measuring ASH neuronal death in the absence of growth. by Cindy Voisine (30589)

Structurally distinct inhibitors of Chk1 decrease Chk1 nuclear fluorescence following heating in a low well volume. by Andrew J. Massey (239469)

ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulat... by Rodrigo A Fuentealba (77901)

“…<p><b>Copyright information:</b></p><p>Taken from "ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity"</p><p>http://www.molecularneurodegeneration.com/content/2/1/14</p><p>Molecular Neurodegeneration 2007;2():14-14.…”